![](/img/cover-not-exists.png)
P2.09-03 Prognostic Value of Mutated KRAS in Circulating Tumor DNA Prior to Therapy in Patients with Lung Adenocarcinoma
Wahl, S.G.F., Dai, H.Y., Emdal, E.F., Ottestad, A.L., Richardsen, E., Halvorsen, T.O., Gronberg, B.H.Volume:
14
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.1652
Date:
October, 2019
File:
PDF, 255 KB
english, 2019